78 Chapter 4 REFERENCES 1. Seitz A, Gardezy J, Pirozzolo G, Probst S, Athanasiadis A, Hill S, et al. Long-Term follow-up in patients with stable angina and unobstructed coronary arteries undergoing intracoronary acetylcholine testing. JACC Cardl Interv. (2020) 13(16):1865–76. doi: 10.1016/j.jcin.2020.05.009 2. Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, et al. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation. (1988) 77(3):535–42. doi: 10.1161/01. CIR.77.3.535 3. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. (2020) 41(3):407– 77. doi: 10.1093/eurheartj/ehz425 4. Feenstra RGT, Seitz A, Boerhout CKM, Bukkems LH, Stegehuis VE, Teeuwisse PJI, et al. Principles and pitfalls in coronary vasomotor function testing. EuroIntervention. (2022) 17(15):1271–80. doi: 10.4244/EIJ-D-21-00402 5. Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. (2017) 38(33):2565–8. doi: 10.1093/eurheartj/ ehv351 6. Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. (2018) 250:16–20. doi: 10.1016/j. ijcard.2017.08.068 7. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J. (2009) 339:b2535. doi: 10.1136/bmj.b2535 8. Arrebola-Moreno AL, Arrebola JP, Moral-Ruiz A, Ramirez-Hernandez JA, Melgares-Moreno R, Kaski JC. Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries. Atherosclerosis. (2014) 236(1):207–14. doi: 10.1016/j.atherosclerosis.2014.07.009 9. Aziz A, Hansen HS, Sechtem U, Prescott E, Ong P. Sex-Related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol. (2017) 70(19):2349–58. doi: 10.1016/j.jacc.2017.09.016 10. Castello R, Alegria E, Merino A, Soria F, Martinez-Caro D. Syndrome of coronary artery spasm of normal coronary arteries. Clinical and angiographic features. Angiology. (1988) 39(1 Pt 1):8–15. doi: 10.1177/000331978803900102 11. Choi BG, Rha SW, Yoon SG, Choi CU, Lee MW, Kim SW. Association of Major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean population. J Am Heart Assoc. (2019) 8(12):e010541. doi: 10.1161/JAHA.118.010541 12. Coma-Canella I, Castano S, Macias A, Calabuig J, Artaiz M. Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol. (2006) 107(2):200–6. doi: 10.1016/j. ijcard.2005.03.008 13. Figueras J, Domingo E, Ferreira I, Lidon RM, Bellera N, Garcia-Dorado D. Typical angina without significant coronary stenosis: comparison of clinical profile, circadian presentation, and long-term followup between patients with and patients without vasospastic angina. Coron Artery Dis. (2013) 24(5):374–80. doi: 10.1097/ MCA.0b013e328362230e
RkJQdWJsaXNoZXIy MTk4NDMw